aluates Reports

$ 0.0

Automative

Global Ibrexafungerp Citrate Tablets Market Research Report 2026

Published Date: 2026-05-15

Report Code: QYRE-Auto-14M20465

BUY CHAPTERS

Global Ibrexafungerp Citrate Tablets Market Research Report 2026

Code: QYRE-Auto-14M20465

Report

2026-05-15

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Scynexis Inc

GlaxoSmithKline PLC

Hansoh Pharma

Ibrexafungerp Citrate Tablets Market Size

The global Ibrexafungerp Citrate Tablets market was valued at US$ 300 million in 2025 and is anticipated to reach US$ 988 million by 2032, at a CAGR of 11.3% from 2026 to 2032.

Ibrexafungerp Citrate Tablets Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Ibrexafungerp Citrate Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Ibrexafungerp Citrate is a novel triterpenoid antifungal agent that exerts fungicidal effects by inhibiting the synthesis of β‑1,3‑glucan in fungal cell walls. It demonstrates potent activity against a variety of pathogenic fungi including Candida species. Administered as an oral tablet in its citrate salt form, it is mainly indicated for the treatment of vulvovaginal candidiasis and can also be used for the prophylaxis and management of invasive fungal infections. With favorable oral absorption, broad antifungal spectrum and good safety profile, it represents a valuable new option for clinical antifungal therapy.

In 2025, global ibrexafungerp citrate production reached approximately 2.1–2.3 million bottles

As the first-in-class oral triterpenoid antifungal drug worldwide, ibrexafungerp citrate holds an important innovative position in the global antifungal market due to its unique mechanism of action, broad-spectrum antifungal activity and favorable safety profile. It is mainly indicated for the treatment and prevention of vulvovaginal candidiasis and recurrent infections, while expanding its indications to areas such as invasive fungal infections. Its market growth is driven by rising global incidence of fungal diseases, increasing drug-resistant strains and limitations of existing therapies. With its differentiated advantages, it complements traditional azoles and echinocandins, showing growth potential in both gynecological anti-infective and systemic antifungal segments. Global commercialization is carried out through collaboration between innovator companies and regional partners. The approval and launch in emerging markets including China has further unlocked incremental space. Despite challenges such as pricing, insurance coverage and market education, the market continues to expand steadily with patent protection, expanded indications and improved clinical recognition, supporting continuous enhancement of long-term market value and competitiveness.

This report delivers a comprehensive overview of the global Ibrexafungerp Citrate Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Ibrexafungerp Citrate Tablets. The Ibrexafungerp Citrate Tablets market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Ibrexafungerp Citrate Tablets market comprehensively. Regional market sizes by Type, by Application, by Combination Therapy, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Ibrexafungerp Citrate Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Ibrexafungerp Citrate Tablets Market Report

Report Metric	Details
Report Name	Ibrexafungerp Citrate Tablets Market
Accounted market size in 2025	US$ 300 million
Forecasted market size in 2032	US$ 988 million
CAGR	11.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Tablets For Oral Suspension
Segment by Combination Therapy	Combination With Azole Antifungals Combination With Echinocandins
Segment by Sales Channels	Hospitals Retail Online
by Application	Vulvovaginal Candidiasis Recurrent Vulvovaginal Candidiasis Invasive Fungal Infections Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Scynexis, GlaxoSmithKline, Hansoh Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Combination Therapy, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Ibrexafungerp Citrate Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Ibrexafungerp Citrate Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Ibrexafungerp Citrate Tablets Market growing?

Ans: The Ibrexafungerp Citrate Tablets Market witnessing a CAGR of 11.3% during the forecast period 2026-2032.

What is the Ibrexafungerp Citrate Tablets Market size in 2032?

Ans: The Ibrexafungerp Citrate Tablets Market size in 2032 will be US$ 988 million.

Who are the main players in the Ibrexafungerp Citrate Tablets Market report?

Ans: The main players in the Ibrexafungerp Citrate Tablets Market are Scynexis, GlaxoSmithKline, Hansoh Pharma

What are the Application segmentation covered in the Ibrexafungerp Citrate Tablets Market report?

Ans: The Applications covered in the Ibrexafungerp Citrate Tablets Market report are Vulvovaginal Candidiasis, Recurrent Vulvovaginal Candidiasis, Invasive Fungal Infections, Others

What are the Type segmentation covered in the Ibrexafungerp Citrate Tablets Market report?

Ans: The Types covered in the Ibrexafungerp Citrate Tablets Market report are Tablets, For Oral Suspension

1 Ibrexafungerp Citrate Tablets Market Overview

1.1 Product Definition

1.2 Ibrexafungerp Citrate Tablets by Type

1.2.1 Global Ibrexafungerp Citrate Tablets Market Value by Type: 2025 vs 2032

1.2.2 Tablets

1.2.3 For Oral Suspension

1.3 Ibrexafungerp Citrate Tablets by Combination Therapy

1.3.1 Global Ibrexafungerp Citrate Tablets Market Value by Combination Therapy: 2025 vs 2032

1.3.2 Combination With Azole Antifungals

1.3.3 Combination With Echinocandins

1.4 Ibrexafungerp Citrate Tablets by Sales Channels

1.4.1 Global Ibrexafungerp Citrate Tablets Market Value by Sales Channels: 2025 vs 2032

1.4.2 Hospitals

1.4.3 Retail

1.4.4 Online

1.5 Ibrexafungerp Citrate Tablets by Application

1.5.1 Global Ibrexafungerp Citrate Tablets Market Value by Application: 2025 vs 2032

1.5.2 Vulvovaginal Candidiasis

1.5.3 Recurrent Vulvovaginal Candidiasis

1.5.4 Invasive Fungal Infections

1.5.5 Others

1.6 Global Ibrexafungerp Citrate Tablets Market Size Estimates and Forecasts

1.6.1 Global Ibrexafungerp Citrate Tablets Revenue 2021–2032

1.6.2 Global Ibrexafungerp Citrate Tablets Sales 2021–2032

1.6.3 Global Ibrexafungerp Citrate Tablets Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Ibrexafungerp Citrate Tablets Market Competition by Manufacturers

2.1 Global Ibrexafungerp Citrate Tablets Sales Market Share by Manufacturers (2021–2026)

2.2 Global Ibrexafungerp Citrate Tablets Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Ibrexafungerp Citrate Tablets Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Ibrexafungerp Citrate Tablets, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Ibrexafungerp Citrate Tablets, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Ibrexafungerp Citrate Tablets, Product Types and Applications

2.7 Global Key Manufacturers of Ibrexafungerp Citrate Tablets, Date of Entry into the Industry

2.8 Global Ibrexafungerp Citrate Tablets Market Competitive Situation and Trends

2.8.1 Global Ibrexafungerp Citrate Tablets Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Ibrexafungerp Citrate Tablets Players Market Share by Revenue

2.8.3 Global Ibrexafungerp Citrate Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Ibrexafungerp Citrate Tablets Market Scenario by Region

3.1 Global Ibrexafungerp Citrate Tablets Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Ibrexafungerp Citrate Tablets Sales by Region: 2021–2032

3.2.1 Global Ibrexafungerp Citrate Tablets Sales by Region: 2021–2026

3.2.2 Global Ibrexafungerp Citrate Tablets Sales by Region: 2027–2032

3.3 Global Ibrexafungerp Citrate Tablets Revenue by Region: 2021–2032

3.3.1 Global Ibrexafungerp Citrate Tablets Revenue by Region: 2021–2026

3.3.2 Global Ibrexafungerp Citrate Tablets Revenue by Region: 2027–2032

3.4 North America Ibrexafungerp Citrate Tablets Market Facts & Figures by Country

3.4.1 North America Ibrexafungerp Citrate Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Ibrexafungerp Citrate Tablets Sales by Country (2021–2032)

3.4.3 North America Ibrexafungerp Citrate Tablets Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Ibrexafungerp Citrate Tablets Market Facts & Figures by Country

3.5.1 Europe Ibrexafungerp Citrate Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Ibrexafungerp Citrate Tablets Sales by Country (2021–2032)

3.5.3 Europe Ibrexafungerp Citrate Tablets Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ibrexafungerp Citrate Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Ibrexafungerp Citrate Tablets Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Ibrexafungerp Citrate Tablets Sales by Region (2021–2032)

3.6.3 Asia Pacific Ibrexafungerp Citrate Tablets Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Ibrexafungerp Citrate Tablets Market Facts & Figures by Country

3.7.1 Latin America Ibrexafungerp Citrate Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Ibrexafungerp Citrate Tablets Sales by Country (2021–2032)

3.7.3 Latin America Ibrexafungerp Citrate Tablets Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Ibrexafungerp Citrate Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Ibrexafungerp Citrate Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Ibrexafungerp Citrate Tablets Sales by Country (2021–2032)

3.8.3 Middle East and Africa Ibrexafungerp Citrate Tablets Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Ibrexafungerp Citrate Tablets Sales by Type (2021–2032)

4.1.1 Global Ibrexafungerp Citrate Tablets Sales by Type (2021–2026)

4.1.2 Global Ibrexafungerp Citrate Tablets Sales by Type (2027–2032)

4.1.3 Global Ibrexafungerp Citrate Tablets Sales Market Share by Type (2021–2032)

4.2 Global Ibrexafungerp Citrate Tablets Revenue by Type (2021–2032)

4.2.1 Global Ibrexafungerp Citrate Tablets Revenue by Type (2021–2026)

4.2.2 Global Ibrexafungerp Citrate Tablets Revenue by Type (2027–2032)

4.2.3 Global Ibrexafungerp Citrate Tablets Revenue Market Share by Type (2021–2032)

4.3 Global Ibrexafungerp Citrate Tablets Price by Type (2021–2032)

5 Segment by Application

5.1 Global Ibrexafungerp Citrate Tablets Sales by Application (2021–2032)

5.1.1 Global Ibrexafungerp Citrate Tablets Sales by Application (2021–2026)

5.1.2 Global Ibrexafungerp Citrate Tablets Sales by Application (2027–2032)

5.1.3 Global Ibrexafungerp Citrate Tablets Sales Market Share by Application (2021–2032)

5.2 Global Ibrexafungerp Citrate Tablets Revenue by Application (2021–2032)

5.2.1 Global Ibrexafungerp Citrate Tablets Revenue by Application (2021–2026)

5.2.2 Global Ibrexafungerp Citrate Tablets Revenue by Application (2027–2032)

5.2.3 Global Ibrexafungerp Citrate Tablets Revenue Market Share by Application (2021–2032)

5.3 Global Ibrexafungerp Citrate Tablets Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Scynexis

6.1.1 Scynexis Company Information

6.1.2 Scynexis Description and Business Overview

6.1.3 Scynexis Ibrexafungerp Citrate Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Scynexis Ibrexafungerp Citrate Tablets Product Portfolio

6.1.5 Scynexis Recent Developments/Updates

6.2 GlaxoSmithKline

6.2.1 GlaxoSmithKline Company Information

6.2.2 GlaxoSmithKline Description and Business Overview

6.2.3 GlaxoSmithKline Ibrexafungerp Citrate Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 GlaxoSmithKline Ibrexafungerp Citrate Tablets Product Portfolio

6.2.5 GlaxoSmithKline Recent Developments/Updates

6.3 Hansoh Pharma

6.3.1 Hansoh Pharma Company Information

6.3.2 Hansoh Pharma Description and Business Overview

6.3.3 Hansoh Pharma Ibrexafungerp Citrate Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Hansoh Pharma Ibrexafungerp Citrate Tablets Product Portfolio

6.3.5 Hansoh Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Ibrexafungerp Citrate Tablets Industry Chain Analysis

7.2 Ibrexafungerp Citrate Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ibrexafungerp Citrate Tablets Production Mode & Process Analysis

7.4 Ibrexafungerp Citrate Tablets Sales and Marketing

7.4.1 Ibrexafungerp Citrate Tablets Sales Channels

7.4.2 Ibrexafungerp Citrate Tablets Distributors

7.5 Ibrexafungerp Citrate Tablets Customer Analysis

8 Ibrexafungerp Citrate Tablets Market Dynamics

8.1 Ibrexafungerp Citrate Tablets Industry Trends

8.2 Ibrexafungerp Citrate Tablets Market Drivers

8.3 Ibrexafungerp Citrate Tablets Market Challenges

8.4 Ibrexafungerp Citrate Tablets Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Scynexis Inc

GlaxoSmithKline PLC

Hansoh Pharma

List of Tables

Table 1. Global Ibrexafungerp Citrate Tablets Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Ibrexafungerp Citrate Tablets Market Value by Combination Therapy (US$ Million), 2025 vs 2032

Table 3. Global Ibrexafungerp Citrate Tablets Market Value by Sales Channels (US$ Million), 2025 vs 2032

Table 4. Global Ibrexafungerp Citrate Tablets Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Ibrexafungerp Citrate Tablets Market Competitive Situation by Manufacturers in 2025

Table 6. Global Ibrexafungerp Citrate Tablets Sales (Units) of Key Manufacturers (2021–2026)

Table 7. Global Ibrexafungerp Citrate Tablets Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Ibrexafungerp Citrate Tablets Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Ibrexafungerp Citrate Tablets Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Ibrexafungerp Citrate Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Ibrexafungerp Citrate Tablets, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Ibrexafungerp Citrate Tablets, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Ibrexafungerp Citrate Tablets, Product Types and Applications

Table 14. Global Key Manufacturers of Ibrexafungerp Citrate Tablets, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Ibrexafungerp Citrate Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Ibrexafungerp Citrate Tablets Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Ibrexafungerp Citrate Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Ibrexafungerp Citrate Tablets Sales by Region (Units), 2021–2026

Table 20. Global Ibrexafungerp Citrate Tablets Sales Market Share by Region (2021–2026)

Table 21. Global Ibrexafungerp Citrate Tablets Sales by Region (Units), 2027–2032

Table 22. Global Ibrexafungerp Citrate Tablets Sales Market Share by Region (2027–2032)

Table 23. Global Ibrexafungerp Citrate Tablets Revenue by Region (US$ Million), 2021–2026

Table 24. Global Ibrexafungerp Citrate Tablets Revenue Market Share by Region (2021–2026)

Table 25. Global Ibrexafungerp Citrate Tablets Revenue by Region (US$ Million), 2027–2032

Table 26. Global Ibrexafungerp Citrate Tablets Revenue Market Share by Region (2027–2032)

Table 27. North America Ibrexafungerp Citrate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Ibrexafungerp Citrate Tablets Sales by Country (Units), 2021–2026

Table 29. North America Ibrexafungerp Citrate Tablets Sales by Country (Units), 2027–2032

Table 30. North America Ibrexafungerp Citrate Tablets Revenue by Country (US$ Million), 2021–2026

Table 31. North America Ibrexafungerp Citrate Tablets Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Ibrexafungerp Citrate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Ibrexafungerp Citrate Tablets Sales by Country (Units), 2021–2026

Table 34. Europe Ibrexafungerp Citrate Tablets Sales by Country (Units), 2027–2032

Table 35. Europe Ibrexafungerp Citrate Tablets Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Ibrexafungerp Citrate Tablets Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Ibrexafungerp Citrate Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Ibrexafungerp Citrate Tablets Sales by Region (Units), 2021–2026

Table 39. Asia Pacific Ibrexafungerp Citrate Tablets Sales by Region (Units), 2027–2032

Table 40. Asia Pacific Ibrexafungerp Citrate Tablets Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Ibrexafungerp Citrate Tablets Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Ibrexafungerp Citrate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Ibrexafungerp Citrate Tablets Sales by Country (Units), 2021–2026

Table 44. Latin America Ibrexafungerp Citrate Tablets Sales by Country (Units), 2027–2032

Table 45. Latin America Ibrexafungerp Citrate Tablets Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Ibrexafungerp Citrate Tablets Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Ibrexafungerp Citrate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Ibrexafungerp Citrate Tablets Sales by Country (Units), 2021–2026

Table 49. Middle East and Africa Ibrexafungerp Citrate Tablets Sales by Country (Units), 2027–2032

Table 50. Middle East and Africa Ibrexafungerp Citrate Tablets Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Ibrexafungerp Citrate Tablets Revenue by Country (US$ Million), 2027–2032

Table 52. Global Ibrexafungerp Citrate Tablets Sales (Units) by Type (2021–2026)

Table 53. Global Ibrexafungerp Citrate Tablets Sales (Units) by Type (2027–2032)

Table 54. Global Ibrexafungerp Citrate Tablets Sales Market Share by Type (2021–2026)

Table 55. Global Ibrexafungerp Citrate Tablets Sales Market Share by Type (2027–2032)

Table 56. Global Ibrexafungerp Citrate Tablets Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Ibrexafungerp Citrate Tablets Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Ibrexafungerp Citrate Tablets Revenue Market Share by Type (2021–2026)

Table 59. Global Ibrexafungerp Citrate Tablets Revenue Market Share by Type (2027–2032)

Table 60. Global Ibrexafungerp Citrate Tablets Price (US$/Unit) by Type (2021–2026)

Table 61. Global Ibrexafungerp Citrate Tablets Price (US$/Unit) by Type (2027–2032)

Table 62. Global Ibrexafungerp Citrate Tablets Sales (Units) by Application (2021–2026)

Table 63. Global Ibrexafungerp Citrate Tablets Sales (Units) by Application (2027–2032)

Table 64. Global Ibrexafungerp Citrate Tablets Sales Market Share by Application (2021–2026)

Table 65. Global Ibrexafungerp Citrate Tablets Sales Market Share by Application (2027–2032)

Table 66. Global Ibrexafungerp Citrate Tablets Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Ibrexafungerp Citrate Tablets Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Ibrexafungerp Citrate Tablets Revenue Market Share by Application (2021–2026)

Table 69. Global Ibrexafungerp Citrate Tablets Revenue Market Share by Application (2027–2032)

Table 70. Global Ibrexafungerp Citrate Tablets Price (US$/Unit) by Application (2021–2026)

Table 71. Global Ibrexafungerp Citrate Tablets Price (US$/Unit) by Application (2027–2032)

Table 72. Scynexis Company Information

Table 73. Scynexis Description and Business Overview

Table 74. Scynexis Ibrexafungerp Citrate Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 75. Scynexis Ibrexafungerp Citrate Tablets Product

Table 76. Scynexis Recent Developments/Updates

Table 77. GlaxoSmithKline Company Information

Table 78. GlaxoSmithKline Description and Business Overview

Table 79. GlaxoSmithKline Ibrexafungerp Citrate Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 80. GlaxoSmithKline Ibrexafungerp Citrate Tablets Product

Table 81. GlaxoSmithKline Recent Developments/Updates

Table 82. Hansoh Pharma Company Information

Table 83. Hansoh Pharma Description and Business Overview

Table 84. Hansoh Pharma Ibrexafungerp Citrate Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 85. Hansoh Pharma Ibrexafungerp Citrate Tablets Product

Table 86. Hansoh Pharma Recent Developments/Updates

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Ibrexafungerp Citrate Tablets Distributors List

Table 90. Ibrexafungerp Citrate Tablets Customers List

Table 91. Ibrexafungerp Citrate Tablets Market Trends

Table 92. Ibrexafungerp Citrate Tablets Market Drivers

Table 93. Ibrexafungerp Citrate Tablets Market Challenges

Table 94. Ibrexafungerp Citrate Tablets Market Restraints

Table 95. Research Programs/Design for This Report

Table 96. Key Data Information from Secondary Sources

Table 97. Key Data Information from Primary Sources

Table 98. Authors List of This Report

List of Figures

Figure 1. Product Picture of Ibrexafungerp Citrate Tablets

Figure 2. Global Ibrexafungerp Citrate Tablets Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Ibrexafungerp Citrate Tablets Market Share by Type: 2025 & 2032

Figure 4. Tablets Product Picture

Figure 5. For Oral Suspension Product Picture

Figure 6. Global Ibrexafungerp Citrate Tablets Market Value by Combination Therapy (US$ Million), 2021–2032

Figure 7. Global Ibrexafungerp Citrate Tablets Market Share by Combination Therapy: 2025 vs 2032

Figure 8. Combination With Azole Antifungals Product Picture

Figure 9. Combination With Echinocandins Product Picture

Figure 10. Global Ibrexafungerp Citrate Tablets Market Value by Sales Channels (US$ Million), 2021–2032

Figure 11. Global Ibrexafungerp Citrate Tablets Market Share by Sales Channels: 2025 vs 2032

Figure 12. Hospitals Product Picture

Figure 13. Retail Product Picture

Figure 14. Online Product Picture

Figure 15. Global Ibrexafungerp Citrate Tablets Market Value by Application (US$ Million), 2021–2032

Figure 16. Global Ibrexafungerp Citrate Tablets Market Share by Application: 2025 & 2032

Figure 17. Vulvovaginal Candidiasis

Figure 18. Recurrent Vulvovaginal Candidiasis

Figure 19. Invasive Fungal Infections

Figure 20. Others

Figure 21. Global Ibrexafungerp Citrate Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 22. Global Ibrexafungerp Citrate Tablets Market Size (US$ Million), 2021–2032

Figure 23. Global Ibrexafungerp Citrate Tablets Sales (Units), 2021–2032

Figure 24. Global Ibrexafungerp Citrate Tablets Average Price (US$/Unit), 2021–2032

Figure 25. Ibrexafungerp Citrate Tablets Report Years Considered

Figure 26. Ibrexafungerp Citrate Tablets Sales Share by Manufacturers in 2025

Figure 27. Global Ibrexafungerp Citrate Tablets Revenue Share by Manufacturers in 2025

Figure 28. Top 5 and Top 10 Global Ibrexafungerp Citrate Tablets Players: Market Share by Revenue in Ibrexafungerp Citrate Tablets in 2025

Figure 29. Ibrexafungerp Citrate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 30. Global Ibrexafungerp Citrate Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 31. North America Ibrexafungerp Citrate Tablets Sales Market Share by Country (2021–2032)

Figure 32. North America Ibrexafungerp Citrate Tablets Revenue Market Share by Country (2021–2032)

Figure 33. United States Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Canada Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Europe Ibrexafungerp Citrate Tablets Sales Market Share by Country (2021–2032)

Figure 36. Europe Ibrexafungerp Citrate Tablets Revenue Market Share by Country (2021–2032)

Figure 37. Germany Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. France Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. U.K. Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Italy Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Russia Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Asia Pacific Ibrexafungerp Citrate Tablets Sales Market Share by Region (2021–2032)

Figure 43. Asia Pacific Ibrexafungerp Citrate Tablets Revenue Market Share by Region (2021–2032)

Figure 44. China Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Japan Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. South Korea Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. India Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Australia Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. China Taiwan Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Southeast Asia Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Latin America Ibrexafungerp Citrate Tablets Sales Market Share by Country (2021–2032)

Figure 52. Latin America Ibrexafungerp Citrate Tablets Revenue Market Share by Country (2021–2032)

Figure 53. Mexico Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Brazil Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Argentina Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Colombia Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Middle East and Africa Ibrexafungerp Citrate Tablets Sales Market Share by Country (2021–2032)

Figure 58. Middle East and Africa Ibrexafungerp Citrate Tablets Revenue Market Share by Country (2021–2032)

Figure 59. Turkey Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Saudi Arabia Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. UAE Ibrexafungerp Citrate Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 62. Global Sales Market Share of Ibrexafungerp Citrate Tablets by Type (2021–2032)

Figure 63. Global Revenue Market Share of Ibrexafungerp Citrate Tablets by Type (2021–2032)

Figure 64. Global Ibrexafungerp Citrate Tablets Price (US$/Unit) by Type (2021–2032)

Figure 65. Global Sales Market Share of Ibrexafungerp Citrate Tablets by Application (2021–2032)

Figure 66. Global Revenue Market Share of Ibrexafungerp Citrate Tablets by Application (2021–2032)

Figure 67. Global Ibrexafungerp Citrate Tablets Price (US$/Unit) by Application (2021–2032)

Figure 68. Ibrexafungerp Citrate Tablets Value Chain

Figure 69. Channels of Distribution (Direct Vs Distribution)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions